These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 22156730

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Antagonistic interactions between yeast [PSI(+)] and [URE3] prions and curing of [URE3] by Hsp70 protein chaperone Ssa1p but not by Ssa2p.
    Schwimmer C, Masison DC.
    Mol Cell Biol; 2002 Jun; 22(11):3590-8. PubMed ID: 11997496
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prion and nonprion amyloids: a comparison inspired by the yeast Sup35 protein.
    Kushnirov VV, Vishnevskaya AB, Alexandrov IM, Ter-Avanesyan MD.
    Prion; 2007 Jun; 1(3):179-84. PubMed ID: 19164899
    [Abstract] [Full Text] [Related]

  • 27. Molecular chaperone Hsp104 can promote yeast prion generation.
    Kryndushkin DS, Engel A, Edskes H, Wickner RB.
    Genetics; 2011 Jun; 188(2):339-48. PubMed ID: 21467567
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Heat shock protein 104 (Hsp104)-mediated curing of [PSI+] yeast prions depends on both [PSI+] conformation and the properties of the Hsp104 homologs.
    Zhao X, Rodriguez R, Silberman RE, Ahearn JM, Saidha S, Cummins KC, Eisenberg E, Greene LE.
    J Biol Chem; 2017 May 26; 292(21):8630-8641. PubMed ID: 28373280
    [Abstract] [Full Text] [Related]

  • 30. Nucleation seed size determines amyloid clearance and establishes a barrier to prion appearance in yeast.
    Villali J, Dark J, Brechtel TM, Pei F, Sindi SS, Serio TR.
    Nat Struct Mol Biol; 2020 Jun 26; 27(6):540-549. PubMed ID: 32367069
    [Abstract] [Full Text] [Related]

  • 31. A new colour assay for [URE3] prion in a genetic background used to score for the [PSI⁺] prion.
    Hong JY, Mathur V, Liebman SW.
    Yeast; 2011 Jul 26; 28(7):555-60. PubMed ID: 21590810
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of charged residues in the N-domain of Sup35 protein on prion [PSI+] stability and propagation.
    Bondarev SA, Shchepachev VV, Kajava AV, Zhouravleva GA.
    J Biol Chem; 2013 Oct 04; 288(40):28503-13. PubMed ID: 23965990
    [Abstract] [Full Text] [Related]

  • 34. [PSI(+) ] prion variant establishment in yeast.
    Sharma J, Liebman SW.
    Mol Microbiol; 2012 Nov 04; 86(4):866-81. PubMed ID: 22998111
    [Abstract] [Full Text] [Related]

  • 35. Life cycle of yeast prions: propagation mediated by amyloid fibrils.
    Inoue Y.
    Protein Pept Lett; 2009 Nov 04; 16(3):271-6. PubMed ID: 19275740
    [Abstract] [Full Text] [Related]

  • 36. Mutations Outside the Ure2 Amyloid-Forming Region Disrupt [URE3] Prion Propagation and Alter Interactions with Protein Quality Control Factors.
    Kumar S, Dine EA, Paddock E, Steinberg DN, Greene LE, Masison DC.
    Mol Cell Biol; 2020 Oct 13; 40(21):. PubMed ID: 32868289
    [Abstract] [Full Text] [Related]

  • 37. Primary sequence independence for prion formation.
    Ross ED, Edskes HK, Terry MJ, Wickner RB.
    Proc Natl Acad Sci U S A; 2005 Sep 06; 102(36):12825-30. PubMed ID: 16123127
    [Abstract] [Full Text] [Related]

  • 38. Specificity of the J-protein Sis1 in the propagation of 3 yeast prions.
    Higurashi T, Hines JK, Sahi C, Aron R, Craig EA.
    Proc Natl Acad Sci U S A; 2008 Oct 28; 105(43):16596-601. PubMed ID: 18955697
    [Abstract] [Full Text] [Related]

  • 39. Heterologous aggregates promote de novo prion appearance via more than one mechanism.
    Arslan F, Hong JY, Kanneganti V, Park SK, Liebman SW.
    PLoS Genet; 2015 Jan 28; 11(1):e1004814. PubMed ID: 25568955
    [Abstract] [Full Text] [Related]

  • 40. De novo [PSI +] prion formation involves multiple pathways to form infectious oligomers.
    Sharma J, Wisniewski BT, Paulson E, Obaoye JO, Merrill SJ, Manogaran AL.
    Sci Rep; 2017 Mar 06; 7(1):76. PubMed ID: 28250435
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.